Literature DB >> 34159171

Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need.

Yu-Jie Zhou1,2, Vincent Wai-Sun Wong3,4, Ming-Hua Zheng1,5,6.   

Abstract

Entities:  

Year:  2021        PMID： 34159171      PMCID： PMC8188132          DOI： 10.21037/hbsn-21-80

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

1.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis.

Authors:  Yu-Jie Zhou; Kenneth I Zheng; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01

3.  Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.

Authors:  Zobair M Younossi; Mazen Noureddin; David Bernstein; Paul Kwo; Mark Russo; Mitchell L Shiffman; Ziad Younes; Manal Abdelmalek
Journal:  Am J Gastroenterol       Date:  2020-12-07       Impact factor: 10.864

4.  Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH.

Authors:  J Boursier; R Anty; L Vonghia; V Moal; T Vanwolleghem; C M Canivet; S Michalak; S Bonnafous; P Michielsen; F Oberti; A Iannelli; L Van Gaal; S Patouraux; O Blanchet; A Verrijken; P Gual; M-C Rousselet; A Driessen; G Hunault; S Bertrais; A Tran; P Calès; S Francque
Journal:  Aliment Pharmacol Ther       Date:  2018-03-25       Impact factor: 8.171

5.  Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.

Authors:  Javier Ampuero; Raluca Pais; Rocío Aller; Rocío Gallego-Durán; Javier Crespo; Carmelo García-Monzón; Jerome Boursier; Eduardo Vilar; Salvatore Petta; Ming-Hua Zheng; Desamparados Escudero; Jose Luis Calleja; Patricia Aspichueta; Moisés Diago; Jose Miguel Rosales; Joan Caballería; Judith Gómez-Camarero; Oreste Lo Iacono; Salvador Benlloch; Agustín Albillos; Juan Turnes; Jesus M Banales; Vlad Ratziu; Manuel Romero-Gómez
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-11       Impact factor: 11.382

6.  The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.

Authors:  Timothy Hardy; Kristy Wonders; Ramy Younes; Guruprasad P Aithal; Rocio Aller; Michael Allison; Pierre Bedossa; Fay Betsou; Jerome Boursier; M Julia Brosnan; Alastair Burt; Jeremy Cobbold; Helena Cortez-Pinto; Chris P Day; Jean-Francois Dufour; Mattias Ekstedt; Sven Francque; Stephen Harrison; Luca Miele; Patrik Nasr; George Papatheodoridis; Salvatore Petta; Dina Tiniakos; Richard Torstenson; Luca Valenti; Adriaan G Holleboom; Hannele Yki-Jarvinen; Andreas Geier; Manuel Romero-Gomez; Vlad Ratziu; Elisabetta Bugianesi; Jörn M Schattenberg; Quentin M Anstee
Journal:  Contemp Clin Trials       Date:  2020-10-09       Impact factor: 2.226

7.  Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score.

Authors:  Aleksandra Klisic; Ludovico Abenavoli; Sharmila Fagoonee; Nebojsa Kavaric; Gordana Kocic; Ana Ninić
Journal:  Minerva Med       Date:  2019-02-14       Impact factor: 4.806

8.  Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Enrica Baldelli; Alessandra Marrazzo; Dante Romagnoli; Giovanni Targher; Amedeo Lonardo
Journal:  Metabolism       Date:  2017-04-13       Impact factor: 8.694

Review 9.  Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.

Authors:  Janae Wentong Wai; Charmaine Fu; Vincent Wai-Sun Wong
Journal:  J Gastroenterol       Date:  2020-05-25       Impact factor: 7.527

10.  Non-invasive fibrosis assessment in non-alcoholic fatty liver disease.

Authors:  Rafael S Rios; Kenneth I Zheng; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Chin Med J (Engl)       Date:  2020-11-20       Impact factor: 2.628
View more
  4 in total

1.  A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease.

Authors:  Xuemei Tao; Lin Chen; Youfei Zhao; Yonggang Liu; Ruifang Shi; Bei Jiang; Yuqiang Mi; Liang Xu
Journal:  Front Med (Lausanne)       Date:  2022-03-23

2.  Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.

Authors:  Qing-Feng Sun; Liang-Jie Tang; Ming-Jie Wang; Pei-Wu Zhu; Yang-Yang Li; Hong-Lei Ma; Ou-Yang Huang; Liang Hong; Gang Li; Christopher D Byrne; Giovanni Targher; Wen-Yue Liu; Yan Lu; Ji-Guang Ding; Ming-Hua Zheng
Journal:  Front Med (Lausanne)       Date:  2022-03-31

3.  Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury.

Authors:  Ruiyuan Yang; Kexin Li; Cailun Zou; Aileen Wee; Jimin Liu; Liwei Liu; Min Li; Ting Wu; Yu Wang; Zikun Ma; Yan Wang; Jingyi Liu; Ang Huang; Ying Sun; Binxia Chang; Qingsheng Liang; Jidong Jia; Zhengsheng Zou; Xinyan Zhao
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 4.  Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.

Authors:  Wah-Kheong Chan; Soek-Siam Tan; Siew-Pheng Chan; Yeong-Yeh Lee; Hoi-Poh Tee; Sanjiv Mahadeva; Khean-Lee Goh; Anis Safura Ramli; Feisul Mustapha; Nik Ritza Kosai; Raja Affendi Raja Ali
Journal:  J Gastroenterol Hepatol       Date:  2022-02-08       Impact factor: 4.369
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.